Vascular grafts
This article was originally published in The Gray Sheet
Executive Summary
An OST computational study of vascular prostheses is underway to assess how the devices affect blood flow and concentration of chemicals activated by the prosthetic material. The study hopes to discover factors that influence graft failure, which could be applied to the design of future endovascular grafts and stents. "Sponsors are increasingly turning to computational modeling to provide answers to problems not answerable by other techniques...particularly...for heart valve technology," the report notes
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.